Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C

Recruiting Observational Study
Niemann-Pick Disease, Type C
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 120
Sex
Any
Study type
Observational
Participants needed
900 (estimated)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will evaluate clinical and laboratory tests that might be useful in determining if an investigational drug can slow the progression of Niemann-Pick Disease, Type C (NPC), a genetic disorder that results in progressive loss of nervous system function. The study will: 1) look for a clinical or biochemical marker that can be used as a measure of response to treatment, and 2) define the rat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: Affected Subjects The following individuals may be enrolled as in this study: * All patients with a diagnosis of NPC, based on clinical presentation, biochemical, or molecular. * Both NPC1 and NPC2 patients. * Patients of any age * Males or females * Any ethnic background E…
Contacts

Derek M Alexander

(301) 827-0387

derek.alexander@nih.gov

CONTACT

Forbes D Porter, M.D.

(301) 435-4432

fdporter@mail.nih.gov

CONTACT